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ERRATUM
In the May 2007 issue of the Journal, in the article entitled
“Hypomorphic Mutations in the Gene Encoding a Key
Fanconi Anemia Protein, FANCD2, Sustain a Significant
Group of FA-D2 Patients with Severe Phenotype” by Kalb
et al. (80:895–910), there were errors in the text and in
table 3.
On page 897, in the “Retroviral Complementation” sec-
tion, the text should read “In addition, cDNAs of the en-
hanced green fluorescent protein (GFP) and FANCA genes
were separately cloned into the vector S11IN….” On page
900, in the “Mutations Affecting Pre-mRNA Splicing” sec-
tion, “splec” should be “splice.” On page 905, in the “Re-
sidual FANCD2 Protein” section, “(data not shown)” should
be “(fig. 8B, right panel).” Therefore, in figure 8, the de-
scription of panel B should be “B, Blood-derived cells from
nonmosaic FA-D2 patients (exemplified 13, 5, 1, 21, 2, 6,
11, and 28) and fibroblasts from mosaic FA-D2 patients
(exemplified 3, 14, and 26) show faint but conspicuous
FANCD2 bands of both species in response to MMC ex-
posure exclusively on overexposed immunoblots, as in-
dicated by the very intense FANCD2 signals of the normal
control LCLs (CON) (patient 13, stimulated PBL; patients
5, 1, 21, 2, 6, 11, and 28, LCLs; patients 3, 14, 26, cultured
fibroblasts; loading control, RAD50).” In the figure 6 leg-
end, two reference numbers were incorrect. The sentence
should be “Mutations identified in the present study are
shown above, mutations reported elsewhere26,27 are indi-
cated below the schematic display of FANCD2 cDNA.”
The revised table 3 contains seven superamplicons that
were actually used in the study. Their numbering corre-
sponds to their order shown in figure 4C. The table has
been modified accordingly.
The authors and the Journal regret these errors.
Table 3. FANCD2 Superamplicon Primers
Superamplicon Containing Exons
Forward Reverse PCR
Product
Size
(bp)Designation
Sequence
(5′r3′) Designation
Sequence
(5′r3′)
I 1 and 2 hFANCD2_exon1_F TATGCCCGGCTAGCACAGAA hFANCD2_super_7_15_R GGCCCACAGTTTCCGTTTCT 4,346
II 10, 11, 12, 13, 14, and 15 hFANCD2_exon10_F GCCCAGCTCTGTTCAAACCA hFANCD2_super_7_15_R TTAAGACCCAGCGAGGTATTC 5,635
III 13, 14, 15, 16, and 17 hFANCD2_super_13_17_F CATGGCAGGAACTCCGATCTTG hFANCD2_super_13_17_R CTCCCTTAAAAGCTCAAAGCTCAAGTTC 8,858
IV 19 and 20 hFANCD2_super_19_22_F ACGTAATCACCCCTGTAATCC hFANCD2_exon20_R TGACAGAGCGAGACTCTCTAA 2,749
V 21, 22, and 23 hFANCD2_21_23_F GCTTCTAGTCACTGTCAGTTCACCAG hFANCD2_21_23_R ACGTTGGCCAGAAAGTAATCTCAG 2,518
VI 22, 23, 24, 25, and 26 hFANCD2_super_22_29_F GGCCTTGTGCTAAGTGCTTTT hFANCD2_exon26_R TCAGGGATATTGGCCTGAGAT 3,252
VII 27, 28, and 29 hFANCD2_exon27_F GCATTCAGCCATGCTTGGTAA hFANCD2_super_22_29_R CACTGCAAACTGCTCACTCAA 3,371
